Introduction {#Sec1}
============

Increasing evidence implicates neuroinflammatory pathways in the development, treatment response, and remission of MDD^[@CR1],[@CR2]^. Dysregulation of three major inflammatory systems is evident in those patients: (a) increased oxidative stress by means of nitric oxide (NO) overproduction, driven by NOS2 (NO synthase 2 or inducible NOS)^[@CR3],[@CR4]^, (b) low-grade chronic pro-inflammatory status driven by CASP1 overproduction^[@CR5],[@CR6]^, and (c) INFG over production driven by Th1 lymphocytes^[@CR7]--[@CR9]^.

Each of these pathways has been investigated in isolation as an antidepressant-like strategy for MDD^[@CR10]--[@CR12]^. However, the complex nature of MDD pathophysiology and the potential interplay between pathways suggests that multi-targeted pharmacotherapeutic approaches might provide more significant benefit than isolated pathway approaches. To investigate the effects of multiple pro-inflammatory mediator deficiencies at baseline and post-stress behaviour, we generated a triple knockout mouse model lacking *Casp1*, *Ifngr* and *Nos2* (*Casp1, Ifngr, Nos2*)^−/−^, and assessed them in a pre-clinical paradigm of stress-induced depressive-like behaviour.

Immune regulation contributes to the maintenance of gut microbiome homeostasis^[@CR13]^. Therefore, changes in inflammatory states are likely to give rise to shifts in gut microbiota composition, potentially contributing to MDD development through a variety of pathways^[@CR10],[@CR14],[@CR15]^. Also, emerging studies implicate the gut microbiota in the regulation of stress responses^[@CR16],[@CR17]^, while depressed patients display abnormal faecal microbiota composition associated with heightened inflammatory signalling^[@CR5],[@CR7],[@CR18]--[@CR21]^.

We therefore further assessed whether: 1) the (*Casp1, Ifngr, Nos2*)^−/−^ model is associated with an altered basal gut microbiota composition compared with wt, and 2) (*Casp1, Ifngr, Nos2*)^−/−^ mice are protected from stress-induced shifts in gut microbiome composition, due to deficits on mediating inflammatory pathways.

Results {#Sec2}
=======

*Casp1*, *Ifngr* and *Nos2* deficiency decreases depressive-like and anxiety-like behaviour {#Sec3}
-------------------------------------------------------------------------------------------

Total floating time in the forced swim test was lower in (*Casp1, Ifngr, Nos2*)^−/−^ mice compared to wt mice (F~1,34~ = 14.618, *P* = 0.001) (Fig. [1a](#Fig1){ref-type="fig"} and Supplementary Table [1](#MOESM1){ref-type="media"}). Swimming and climbing behaviours were increased in (*Casp1, Ifngr, Nos2*)^−/−^ mice compared to wt mice (respectively F~1,34~ = 25.256, *P* = 0.001, Fig. [1b](#Fig1){ref-type="fig"} and F~1,34~ = 5.929, *P* = 0.020, Fig. [1c](#Fig1){ref-type="fig"}). Similarly, preference for a 1% sucrose solution in the sucrose preference test was increased in the (*Casp1, Ifngr, Nos2*)^−/−^ genotype compared to wt mice (F~1,34~ = 23.331, *P* \< 0.001) (Fig. [1d](#Fig1){ref-type="fig"}). Moreover, (*Casp1, Ifngr, Nos2*)^−/−^ mice spent more time in the open arms of the elevated plus maze compared to wt mice (F~1,34~ = 15.480, *P* \< 0.001) (Fig. [2a](#Fig2){ref-type="fig"}) and displayed an increased open/closed arms entries ratio (F~1,34~ = 17.302, *P* \< 0.001); in contrast, no differences were observed in the total time spent in the centre of the open field arena between (*Casp1, Ifngr, Nos2*)^−/−^ and wt mice (F~1,34~ = 0.200, *P* = 0.658) (Fig. [2b](#Fig2){ref-type="fig"}) and in the ratio centre/total distance in the open field test (F~1,34~ = 3.330, P = 0.077). In the open field test, the (*Casp1, Ifngr, Nos2*)^−/−^ genotype was associated with a higher number of faecal boli (F~1,34~ = 4.128, *P* = 0.050) (Fig. [2c](#Fig2){ref-type="fig"}).Figure 1*Casp1*, *Ifngr* and *Nos2* deficiency decreases depressive-like behaviour. (**a**) (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed decreased floating time in the forced swim test in comparison to wild-type (wt) mice while displaying (**b**) increased swimming and (**c**) climbing behaviours. Moreover, (**d**) (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed an increased preference for a 1% sucrose solution. Data are presented as means ± s.e.m. Genotype effect \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; stress effect ^+^*P* \< 0.05; ^++^*P* \< 0.01; ^+++^*P* \< 0.001; genotype\*stress effect ^\#^*P* \< 0.05; ^\#\#^*P* \< 0.01; ^\#\#\#^*P* \< 0.001. wt = wild-type; BL = baseline; CUS = after unpredictable chronic stress paradigm; wt n = 16; (*Casp1, Ifngr, Nos2*)^−/−^ n = 20.Figure 2*Casp1*, *Ifngr* and *Nos2* deficiency decreases anxiety-like behaviour. (**a**) (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed increased time spent in the open arms of the elevated plus maze but (**b**) similar time in the centre area of the open field test. The (*Casp1, Ifngr, Nos2*)^−/−^ genotype had a main effect on (**c**) the number of defecations during the open field test, which was driven by the increased number of faecal boli in (*Casp1, Ifngr, Nos2*)^−/−^ mice following CUS, while this parameter remained unchanged in wt mice. Data are presented as means ± s.e.m. Genotype effect \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; stress effect ^+^*P* \< 0.05; ^++^*P* \< 0.01; ^+++^*P* \< 0.001; genotype\*stress effect ^\#^*P* \< 0.05; ^\#\#^*P* \< 0.01; ^\#\#\#^*P* \< 0.001; wt = wild-type; BL = baseline; CUS = chronic unpredictable stress paradigm; wt n = 16; (*Casp1, Ifngr, Nos2*)^−/−^ n = 20.

*Casp1*, *Ifngr* and *Nos2* deficiency affects the response to chronic unpredictable stress (CUS) {#Sec4}
-------------------------------------------------------------------------------------------------

Following 28 days of CUS, the preference for a 1% sucrose solution in the sucrose preference test varied as a function of genotype (F~1,34~ = 17.485, *P* \< 0.001) (Fig. [1d](#Fig1){ref-type="fig"}). Wt mice showed a \~74% decrease in sucrose preference compared to baseline (F~1,34~ = 57.25 *P* \< 0.001), while (*Casp1, Ifngr, Nos2*)^−/−^ mice showed a decrease of \~16% (F~1,34~ = 4.78, *P* = 0.036), reaching an after-stress sucrose preference of 74.2%.

In the open field test, a significant stress-genotype interaction was observed for total distance travelled (F~1,34~ = 11.091, *P* = 0.002) (Fig. [3a](#Fig3){ref-type="fig"}). This result was driven by the 17.5% decrease in locomotor activity in (*Casp1, Ifngr, Nos2*)^−/−^ mice following stress (F~1,34~ = 24.68, *P* \< 0.001), while the distance travelled by wt mice was unchanged (F~1,34~ = 0, *P* = 0.981) compared to baseline. Similarly, a significant stress-genotype interaction was observed for the average moving velocity in the open field test (F~1,34~ = 11.154, *P* = 0.002) (Fig. [3b](#Fig3){ref-type="fig"}). While the average velocity recorded for wt mice was unchanged (F~1,34~ = 0, *P* = 0.979) following CUS, (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed a statistically significant 17.6% reduction (F~1,34~ = 24.80, *P* \< 0.001). A significant stress-genotype interaction was recorded for the number of faecal boli in the open field test (F~1,34~ = 14.285, *P* \< 0.001) (Fig. [2c](#Fig2){ref-type="fig"}). While this measure did not differ significantly between genotypes at baseline (F~1,34~ = 2.11, *P* = 0.155), and was unchanged in wt mice following chronic stress (F~1,34~ = 0.58, *P* = 0.453), it was increased in (*Casp1, Ifngr, Nos2*)^−/−^ mice following stress (68.4% increase, F~1,34~ = 23.23, *P* \< 0.001).Figure 3*Casp1*, *Ifngr* and *Nos2* deficiency increases locomotor activity. (**a**) (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed increased locomotor activity and (**b**) average moving velocity in the open field test. Moreover, (**c**) (*Casp1, Ifngr, Nos2*)^−/−^ genotype had a main effect on the total number of entries in any of the arms of the elevated plus maze, irrespective of them being open or closed. All those parameters showed a stress-genotype interaction, with a common trend of being decreased as a result of *Casp1, Ifngr* and *Nos2* deficiency following chronic unpredictable stress (CUS). Data are presented as means ± s.e.m. Genotype effect \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; stress effect ^+^*P* \< 0.05; ^++^*P* \< 0.01; ^+++^*P* \< 0.001; genotype\*stress effect ^\#^*P* \< 0.05; ^\#\#^*P* \< 0.01; ^\#\#\#^*P* \< 0.001; wt = wild-type mice; BL = baseline; wt n = 16; (*Casp1, Ifngr, Nos2*)^−/−^ n = 20.

*Casp1*, *Ifngr* and *Nos2* deficiency increases locomotor activity {#Sec5}
-------------------------------------------------------------------

*Casp1*, *Nos2* and *Ifngr* deficiency was associated with increased locomotor activity (F~1,34~ = 58.883, *P* \< 0.001; Fig. [3a](#Fig3){ref-type="fig"}) and average moving velocity (F~1,34~ = 58.777, *P* \< 0.001; Fig. [3b](#Fig3){ref-type="fig"}) in the open field test in comparison to wt mice. Furthermore, the number of centre visits but not the total time (Fig. [2b](#Fig2){ref-type="fig"}) spent in the centre was increased in (*Casp1, Ifngr, Nos2*)^−/−^ mice (respectively F~1,34~ = 35.424, *P* \< 0.001 and F~1,34~ = 0.200, *P* = 0.658) in the open field test. Moreover, (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed increased number of entries in the closed arms of the elevated plus maze (F~1,34~ = 64.426, *P* \< 0.001) and in the total number of entries in any of the arms, irrespective of whether they were open or closed (F~1,34~ = 20.348, *P* \< 0.001) (Fig. [3c](#Fig3){ref-type="fig"}).

*Casp1*, *Ifngr* and *Nos2* deficiency does not affect ACTH and CORT plasma levels following stress {#Sec6}
---------------------------------------------------------------------------------------------------

At the endpoint of the experiment, *Casp1, Ifngr* and *Nos2* deficiency was not associated with altered plasma levels of ACTH (t~2,25~ = 0.1465, *P* = 0.8847) (Fig. [4a](#Fig4){ref-type="fig"}) or CORT (t~2,28~ = 0.3851, *P* = 0.7031) (Fig. [4b](#Fig4){ref-type="fig"}) when compared to wt mice.Figure 4*Casp1*, *Ifngr* and *Nos2* deficiency does not affect the levels of adrenocorticotropic hormone and corticosterone following chronic unpredictable stress. (**a**) (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed similar levels of adrenocorticotropic hormone (ACTH), and (**b**) corticosterone (CORT) compared to wild-type (wt) mice at euthanasia. Data are presented as means ± s.e.m. n.s. = not significant. ACTH wt n = 14, *(Casp1, Ifngr, Nos2*)^−/−^ n = 13; CORT wt n = 12, *(Casp1, Ifngr, Nos2*)^−/−^ n = 18.

CUS affects anxiety- and depressive-like behaviour {#Sec7}
--------------------------------------------------

28-day CUS exposure exacerbated depressive-like behaviour, as measured by increased floating (F~1,34~ = 4.299, *P* = 0.046; Fig. [1a](#Fig1){ref-type="fig"}) and decreased climbing behaviours in the forced swim test (F~1,34~ = 6.545, *P* = 0.015; Fig. [1c](#Fig1){ref-type="fig"}). Moreover, CUS induced anhedonia, as measured by a decreased preference for a 1% sucrose solution in the sucrose preference test (F~1,34~ = 50.384, *P* \< 0.001; Fig. [1d](#Fig1){ref-type="fig"}). Furthermore, CUS increased anxiety-like behaviour, as it decreased the time spent in the open arms of the elevated plus maze (F~1,34~ = 10.423, *P* = 0.003; Fig. [2a](#Fig2){ref-type="fig"}), decreased the open/closed arms entries ratio (F~1,34~ = 15.595, *P* \< 0.001) and decreased the time spent in the centre section of the open field test arena (F~1,34~ = 12.583, *P* \< 0.001; Fig. [2b](#Fig2){ref-type="fig"}). However, no differences were observed in the centre distance/total distance ratio in the open field test (F~1,34~ = 2.442, *P* = 0.127).

*Casp1*, *Ifngr* and *Nos2* deficiency affects gut microbiome composition {#Sec8}
-------------------------------------------------------------------------

To determine whether *Casp1, Ifngr* and *Nos2* deficiency influenced the gut microbiota composition, faecal samples were analysed by 16S rRNA sequencing (Supplementary Fig. [2](#MOESM1){ref-type="media"}). Alpha diversity analysis indicated that the faecal microbial community of (*Casp1, Ifngr, Nos2*)^−/−^ mice had significantly increased richness (number of bacterial taxa observed), evenness and diversity when compared to wt (*P* \< 0.0001) (Supplementary Fig. [3](#MOESM1){ref-type="media"}). Besides, the faecal microbiota composition of wt and (*Casp1, Ifngr, Nos2*)^−/−^ mice differed significantly, as determined by permutational ANOVA (PERMANOVA) analysis (*P*(perm) = 0.0001, Pseudo-F = 38.22, 9950 permutations).

Comparison of genus level relative abundances between the groups using LEfSe analysis indicated that the relative abundance of several genera within the Lachnospiraceae family including *Anaerofustis, Marvinbryantia,* and *Roseburia*, as well as *Ruminicococcus* and *Ruminiclostridium*, *Streptococcus, Dialister*, and *Veillonella* were significantly higher in (*Casp1, Ifngr, Nos2*)^−/−^ mice (Fig. [5](#Fig5){ref-type="fig"}). Significantly higher relative abundances were also observed for other genera, including *Bacteroides, Odoribacter, Prevotellaceae UCG-001*, and *Alistipes* in (*Casp1, Ifngr, Nos2*)^−/−^ mice. The relative abundance of S24-7 (a member of the order Bacteroidales) was significantly lower in (*Casp1, Ifngr, Nos2*)^−/−^ mice. Also, the relative abundance of *Bifidobacterium, Allobaculum, Turicibacter*, and the mucin-degrading bacterium *Akkermansia* were significantly lower in (*Casp1, Ifngr, Nos2*)^−/−^ mice.Figure 5Taxonomic cladogram based on LEfSe analysis of bacterial taxa identified by 16S rRNA sequencing of faecal samples. Taxa that are enriched in wt and (*Casp1, Ifngr, Nos2*)^−/−^ faecal samples are indicated in green and red, respectively. Differential taxa were determined based on an LDA threshold score of \>3 and a statistical significance level of 0.05.

*Casp1*, *Ifngr* and *Nos2* deficiency affects the change in gut microbiota composition in response to chronic stress {#Sec9}
---------------------------------------------------------------------------------------------------------------------

Assessment of the faecal microbial community at baseline and after 28 days of CUS treatment showed no significant changes in measures of richness, evenness and diversity in (*Casp1, Ifngr, Nos2*)^−/−^ mice following stress (*P* \> 0.05) (Supplementary Fig. [4](#MOESM1){ref-type="media"}). Significant increases in microbial evenness were observed for wt mice following stress (*P* = 0.004), but not for (*Casp1, Ifngr, Nos2*)^−/−^ mice, when compared to their respective baselines. Microbial richness or diversity did not differ in either genotype when subject to CUS (*P* \> 0.005). However, stochastic changes for microbial richness, which include significant increases in the wt control group and a significant decrease in the (*Casp1, Ifngr, Nos2*)^−/−^ control group were observed. PERMANOVA analysis indicated a significant interaction between genotype, time and treatment on the faecal microbiota composition (*P*(perm) = 0.017, Pseudo-F = 2.978, 9939 permutations).

To determine the influence of stress on faecal microbiota, pairwise comparisons between pre- and post-treatment samples were performed for all groups. CUS for 28 days significantly altered the faecal microbiota of wt mice (*P*(perm) = 0.0012, t = 3.213, 9931 permutations). Significant compositional changes were also observed in control (*Casp1, Ifngr, Nos2*)^−/−^ (*P*(perm) = 0.004, t = 3.049, 9929 permutations) and stressed (*Casp1, Ifngr, Nos2*)^−/−^ mice (*P*(perm) = 0.010, t = 1.739, 9915 permutations). Bacterial taxa that were altered in wt or (*Casp1, Ifngr, Nos2*)^−/−^ mice as a result of CUS were identified by CAP analysis. Based on CAP biplots, bacterial taxa in the opposing quadrants separating the pre- and post-chronic stress groups for the wt (Fig. [6A](#Fig6){ref-type="fig"}) or (*Casp1, Ifngr, Nos2*)^−/−^ mice (Fig. [6B](#Fig6){ref-type="fig"}) were identified for further statistical analysis. The bacterial taxa *Lactobacillus* and S24-7 were found to contribute substantially to the compositional differences observed in wt mice following stress, while the taxa *Acetatifactor, Odoribacter, Turicibacter, Ruminococcus1, Faecalibaculum*, Gastranaerophilales, and Ruminococcaceae UCG-010 were found to contribute to the differences in the (*Casp1, Ifngr, Nos2*)^−/−^ genotype following stress exposure. While the taxon *Bifidobacterium* was not identified by CAP analysis, further comparisons were also performed for this taxon due to its documented contribution to the stress response^[@CR22],[@CR23]^.Figure 6Canonical analysis of principal coordinates (CAP) biplot constrained by time and treatment. The biplot was determined based on a Spearman's correlation score of 0.4. Only bacterial taxa in the two opposing quadrants separating the CUS (chronic unpredictable stress) group pre- and post-treatment are indicated.

Pairwise comparison of the pre- and post-treatment relative abundances of bacterial taxa confirmed a significant reduction in the relative abundance of *Lactobacillus* in wt mice following stress (FDR *P* = 0.018), but not in (*Casp1, Ifngr, Nos2*)^−/−^ mice (Fig. [7A](#Fig7){ref-type="fig"}). An increased relative abundance of *Bifidobacterium* (FDR *P* = 0.028) (Fig. [7B](#Fig7){ref-type="fig"}), *Faecalibaculum* (FDR *P* = 0.029) (Fig. [7C](#Fig7){ref-type="fig"}), *Ruminococcus1* (FDR *P* = 0.029) (Fig. [7D](#Fig7){ref-type="fig"}) and Gastranaerophilales (FDR *P* = 0.036) (Fig. [7E](#Fig7){ref-type="fig"}) were observed in (*Casp1, Ifngr, Nos2*)^−/−^ mice subjected to CUS, and not in the control groups. Significant decreases in the relative abundance of S24-7 were observed in wt CUS mice (FDR *P* = 0.018) but not in (*Casp1, Ifngr, Nos2*)^−/−^ CUS mice, although increased relative abundance was observed in (*Casp1, Ifngr, Nos2*)^−/−^ control mice (FDR *P* = 0.049) (Fig. [7F](#Fig7){ref-type="fig"}). Ruminococcaceae UCG-010 (FDR *P* = 0.029) and *Turicibacter* (FDR *P* = 0.029) relative abundances significantly increased in the (*Casp1, Ifngr, Nos2*)^−/−^ CUS group and the control groups, independent of genotype \[(*Casp1, Ifngr, Nos2*)^−/−^ (FDR *P* = 0.048) and wt (FDR *P* = 0.018)\].Figure 7Relative abundance of selected bacterial taxa that were identified to be differential due to chronic stress. Identification of bacterial taxa was based on the CAP biplots. Pairwise comparison between time-points was performed for each group using the Wilcoxon test based on a statistical significance level of 0.05. CUS, chronic unpredictable stress.

Discussion {#Sec10}
==========

Increasing evidence suggests a dysregulation of neuroinflammatory pathways and a potential alteration of gut microbiome equilibrium in MDD. We aimed to determine whether genetic deletion of *Casp1*, *Nos2* and *Ifngr* affects depression- and anxiety-like behaviours in mice, either in the absence of stress or in response to CUS. Furthermore, we also determined whether faecal microbiota composition was changed as a result of altered genotype, either in isolation or when combined with chronic stress.

Mice deficient in *Casp1, Ifngr* and *Nos2* displayed decreased depressive-like behaviour at baseline, as measured by decreased floating time in the forced swim test, and increased hedonic-like behaviour, as measured by increased sucrose preference. Moreover, (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed decreased levels of anxiety-like behaviour in the elevated plus maze, as they spent more time in the open arms of the maze compared to wt mice. These mice also exhibited increased locomotor activity and moving velocity.

After 28 days of CUS exposure, we observed a different stress response in *(Casp1, Ifngr, Nos2)*^−/−^ mice. CUS increased floating and decreased swimming and struggling time, as reported previously^[@CR24],[@CR25]^. While CUS decreased sucrose preference in both wt and (*Casp1, Ifngr, Nos2*)^−/−^ genotypes, the decrease observed in wt mice was greater and fell below the anhedonic threshold of 65% preference, while the decrease in (*Casp1, Ifngr, Nos2*)^−/−^ mice did not, suggesting that (*Casp1, Ifngr, Nos2*)^−/−^ mice are protected from developing anhedonic-like behaviour following stress. In accordance with this finding, inhibition of hippocampal NOS2 was shown to prevent the decrease in sucrose preference following CUS^[@CR26]^. Similarly, NOS2 inhibition results in antidepressant-like effects in mice while preventing the exacerbation of depressive-like behaviour^[@CR11]^. Accordingly, it was reported that *Ifng* deficiency affects basal emotionality while blunting some of the behavioural and biochemical responses to chronic stressors^[@CR12]^. *Casp1*^−/−^ mice have decreased basal anxiety and depressive-like behaviour and decreased exacerbation of those behaviours following stress exposure^[@CR27]^. Simultaneously inhibiting *Casp1, Ifngr* and *Nos2* may result in a complex neuro-behavioural phenotype, different from individual gene knockouts, which decreases anxiety- and depressive-like behaviours at baseline, while preventing the exacerbation of anhedonic- but not of depressive- or anxiety-like behaviours following chronic stress exposure.

(*Casp1, Ifngr, Nos2*)^−/−^ mice, but not wt mice, displayed a higher number of faecal pellets excreted during the open field test following stress exposure. Similar effects have been reported in germ-free mice and rats exposed to stress^[@CR28],[@CR29]^. It has been hypothesised that such increases result from stress-induced colonic hypermotility and hyperalgesia^[@CR28],[@CR29]^. This finding is in contrast to a previous report that wt, but not *Casp1*^−/−^ mice, displayed an increased number of defecations in the open field test following chronic restraint stress, which was hypothesized to reflect stress resilience in *Casp1*^−/−^ mice^[@CR27]^. These apparently contrasting findings might be due to the different stress paradigms used in the present study and/or to the different gut microbiome composition of the (*Casp1, Ifngr, Nos2*)^−/−^ genotype. Although studying a causal correlation between faecal output and gut microbiome composition was beyond the scope of this study, it cannot be excluded that changes in faecal output might be mediated by the observed changes in gut bacteria composition between genotypes.

There are many potential explanations for the increased locomotor activity displayed by (*Casp1, Ifngr, Nos2*)^−/−^ mice. Pre-clinical studies have identified several systems that modulate spontaneous locomotor activity such as the dopaminergic system, the glutamatergic system, and the caspase 1 system^[@CR27],[@CR30]--[@CR33]^. Hence, it could be hypothesized that (*Casp1, Ifngr, Nos2*)^−/−^ mice have increased levels of movement-related neurotransmitters, such as dopamine or glutamate. In order to test this hypothesis, future studies might interrogate monoamines levels in brain regions that are relevant to locomotion (e.g., substantia nigra and striatum) and MDD (e.g., prefrontal cortex and hippocampus) in the transgenic model used in this study. If (*Casp1, Ifngr, Nos2*)^−/−^ mice indeed have increased levels of dopamine and/or glutamate, they might prove useful as pre-clinical models of Parkinson's disease. In this disease, the main neurodegenerative features include inflammation-mediated loss of dopaminergic neurons in areas involved with movement and locomotor activity, such as the substantia nigra and the striatum^[@CR34]^. Unsurprisingly, it has been shown that the CASP1 and CASP3 inhibitor minocycline prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease^[@CR35]^.

Faecal microbiota analysis indicated significant compositional differences between (*Casp1, Ifngr, Nos2*)^−/−^ and wt mice. Notably, rather than affecting the gut microbiota as a whole, the deletion of *Casp1, Ifngr* and *Nos2* genes result in specific and reproducible changes in the relative abundance of discrete bacterial taxa. Previous studies have shown the effect of *Casp1*^−/−^ gene knockout on gut microbiota composition^[@CR36],[@CR37]^. These studies indicated an overrepresentation of Prevotellaceae in *Casp1*^−/−^ mice, which were recapitulated in the (*Casp1, Ifngr, Nos2*)^−/−^ genotype in this study. However, in contrast to our findings, the *Casp1*^−/−^ mice described by Brinkman and colleagues exhibited decreased Lachnospiraceae relative abundance, while another study showed that *Ifng* and *Ifngr*-deficient mice had decreased abundance of *Bacteroides/Prevotella* or bifidobacteria^[@CR37],[@CR38]^. The discrepancy in taxa relative abundances could be due to the effect on gut microbiome composition of multiple, as opposed to single, gene deletions. Previous studies have shown that deletion of genes involved in immune function and exposure to opportunistic pathogens can influence commensal microbiota composition^[@CR39]^.

Exposure to CUS for 28 days resulted in a significant decrease in the relative abundance of *Lactobacillus* in wt mice, compared to baseline levels, consistent with trends demonstrated in other CUS studies^[@CR40]^ and pre-clinical models of social stress^[@CR41],[@CR42]^. Accordingly, decreased *Lactobacillus* levels have been reported in MDD patients^[@CR43]^. Interestingly, *Lactobacillus* levels did not decrease in (*Casp1, Ifngr, Nos2*)^−/−^ mice after CUS, suggesting that their genetic makeup may provide resistance towards *Lactobacillus* shifts and that this trait might be involved in their observed resilience to developing anhedonic-like behaviour. *Lactobacillus* has been suggested to have beneficial effects such as reducing levels of TNFA and IFNG in human intestinal epithelial cells^[@CR44]^, and those cytokines are associated with MDD^[@CR45]^ and pre-clinical MDD models^[@CR20]^. Indeed, monocolonisation of germ-free mice with *Lactobacillus plantarum* PS128 improves anxiety-like behaviour and increases striatal serotonin and dopamine levels^[@CR20]^, while chronic treatment with *Lactobacillus rhamnosus* reduces corticosterone levels in a vagal-dependent manner^[@CR46]^.

The relative abundance of *Bifidobacterium, Faecalibaculum* and *Ruminococcus* significantly increased in (*Casp1, Ifngr, Nos2*)^−/−^ mice subjected to CUS treatment but not in wt CUS mice or those in the control treatment groups. Our findings are consistent with our previous study, which showed that mice subjected to chronic restraint stress had reduced levels of *Bifidobacterium*^[@CR27]^. Increased *Bifidobacterium* levels are associated with resilience to chronic social defeat stress, while *Bifidobacterium* supplementation increases resilience status in previously susceptible mice^[@CR23]^. Monocolonisation of germ-free mice with *Bifidobacterium infantis* reverses the exaggerated HPA stress response observed in these mice, potentially by preventing the elevation of stress hormones such as ACTH and CORT^[@CR22]^.

*Ruminococcus* and *Bifidobacterium*, which were increased in (*Casp1, Ifngr, Nos2*)^−/−^ mice following stress, are both able to produce short chain fatty acids (SCFA)^[@CR47]^. Similarly, *Faecalibaculum* was also increased and can produce lactic acid, a precursor of the SCFA butyrate^[@CR48]^. Given that SCFA may play a role in reducing stress responses by reducing intestinal epithelial barrier permeability^[@CR17]^, it cannot be excluded that the increase of those taxa in (*Casp1, Ifngr, Nos2*)^−/−^ mice following stress might be involved in their resilience to developing anhedonic-like behaviour.

Limitations of the Study {#Sec11}
========================

The mouse model used in this study simultaneously lacks three genes, making the assignment of observed effects to particular proteins difficult. The rationale to generate this model stemmed from the evidence that each single knockout of these genes displays altered responses to stress or antidepressant-like phenotypes^[@CR10]--[@CR12]^; therefore, we hypothesized that by combining these knockouts, the effects might be additive and result in a greater antidepressant-like phenotype. In order to bypass this limitation, it might prove valuable to compare the present results with single KO mouse models for each of the genes investigated, while generating combinations of double KOs to ascertain if they have greater antidepressant-like behaviour than the respective individual KOs. Another limitation of this study is that, although the circulating levels of adrenocorticotropic hormone and corticosterone were measured following CUS, such measurements were not performed at the beginning of the stress regime. Further studies should determine whether (*Casp1, Ifngr, Nos2*)^−/−^ mice present altered levels of ACTH and/or CORT at baseline. Lastly, the changes in gut microbiome observed between genotypes and stress groups are correlative nature, rather than causal.

Conclusions {#Sec12}
===========

In conclusion, we investigated the effects of simultaneous *Casp1*, *Ifngr* and *Nos2* gene deletion in a CUS model of stress-induced depressive-like behaviour. (*Casp1, Ifngr, Nos2*)^−/−^ mice displayed decreased levels of depressive- and anxiety-like behaviour while exhibiting increased locomotor activity and moving velocity. Following chronic stress exposure, (*Casp1, Ifngr, Nos2*)^−/−^ mice present an attenuated anhedonic-like behaviour compared to wt mice while presenting no alterations in ACTH and CORT plasma levels compared to wt at the time of euthanasia. Correlative faecal microbiota changes were observed as a function of genotype, stress exposure, and genotype-stress interaction. Future studies are needed to investigate the clinical potential of inhibiting these pro-inflammatory signalling pathways in MDD.

Methods {#Sec13}
=======

All procedures were approved by the South Australian Health and Medical Research Institute (SAHMRI) Ethics committee and are in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes (8^th^ edition, 2013). Male C57BL/6 J mice (wild-type, wt, n = 26) aged 60 days were obtained from the SAHMRI Bioresources Facility (Adelaide, Australia). Age-matched (*Casp1, Ifngr, Nos2*)^−/−^ mice (n = 30) with C57BL/6 J background were generated by back-crossing mice with individual gene deletions^[@CR49]--[@CR51]^.

Chronic unpredictable stress {#Sec14}
----------------------------

The CUS protocol consisted of 28 days exposure to randomly scheduled, low and mild intensity social and environmental stressors, applied each day during the light phase of the light cycle. Briefly, the stressors were: (a) restraint, (b) removal of bedding and nesting material, (c) soiled bedding, (d) 45° cage tilting, (e) predator stress, (f) forced swim test, (g) fasting, (h) social stress, (i) light cycle disruption and (j) light cycle reversal (for detailed procedures refer to Supplementary Table [2](#MOESM1){ref-type="media"} and Supplementary Methods).

Behavioural testing {#Sec15}
-------------------

Mice were submitted to the open field, elevated plus maze, forced swim and sucrose preference tests at baseline and following CUS. All tests were video-recorded and analysed using Ethovision XT 10 software (Noldus, Wageningen, Holland) for behaviour recognition and scoring. See Supplementary Fig. [1](#MOESM1){ref-type="media"} for a timeline of experimental procedures.

Adrenocorticotropic hormone (ACTH) and corticosterone (CORT) measurements {#Sec16}
-------------------------------------------------------------------------

Plasma ACTH and plasma CORT level were measured respectively by a competitive inhibition ELISA kit (Cloud-Clone Corp., Wuhan, Hubei, China) and a competitive immunoassay ELISA kit (Enzo Life Sciences, Farmingdale, New York, USA) following the manufacturers' instructions.

16S rRNA gene amplicon sequencing and bioinformatics analysis {#Sec17}
-------------------------------------------------------------

Fresh faecal pellets were collected between 10--11 am with sterile toothpicks on experimental day 41 during weighing procedures and placed into sterile 1.5 mL Eppendorf tubes and stored at −80 °C. DNA was extracted from faecal samples using the DNeasy PowerSoil HTP 96 kit (Qiagen, Hilden, Germany) optimized for the Biomek 4000 Automation Workstation (Beckman Coulter Inc., Lane Cove, NSW, Australia). Barcoded amplicons of the V4 hypervariable region of the bacterial 16S rRNA gene were generated from the faecal DNA extracts based on the Illumina Miseq. 16S Metagenomic Sequencing Library Preparation protocol with modifications, as described previously^[@CR52]^, and sequencing was performed on an Illumina Miseq platform. A detailed description of library preparation and sequencing are provided in the Supplementary Methods.

Bioinformatics analysis of paired-end sequences was performed using Quantitative Insights Into Microbial Ecology (QIIME, v1.9.1)^[@CR53]^ based on a previously described bioinformatics pipeline^[@CR54]^. Paired forward and reverse barcoded reads were quality filtered and merged using the Paired-End read merger (PEAR v0.9.10)^[@CR55]^. Chimera filtering (USEARCH, v6.1)^[@CR56]^ and open reference operational taxonomic unit (OTU) assignment was performed against the SILVA reference database (release 128) that were clustered at 97% identity. Only sequences with \>80% identity to the reference sequence were used for OTU assignment step. All samples had spurious OTUs removed and were subsampled to the lowest sequence depth at 7,354 sequence reads, providing an average Good's coverage score of 97.13% (±0.7%).

Statistical analysis {#Sec18}
--------------------

Power analysis was performed based on the effect size seen in a previous pilot study investigating the effects of simultaneous *Casp1, Ifngr and Nos2* deficiency on total floating time in the forced swim test (our primary outcome measure). Statistical analyses of the behavioural tests were performed using the Statistical Package for the Social Sciences version 23.0 for Windows (SPSS, Chicago, Illinois) using a general linear model for repeated measures (repeated measures ANOVA). The effects of genotype, stress, treatment and their interaction were explored and the significance set at *P* ≤ 0.05. Statistically significant stress-genotype interactions were further assessed as described previously^[@CR57]^. ELISA data were analysed by two-tailed unpaired student T-test. Alpha diversity scores of observed species, Simpson (1-D) and Shannon were calculated using QIIME^[@CR53]^. Beta-diversity analyses were performed using the PRIMER software (v6, PRIMER-E Ltd, Plymouth, UK). Comparison of microbiota composition between groups was performed on weighted Unifrac distances using a permutational multivariate analysis of variance (PERMANOVA) test with 9,999 permutations. LEfSe (linear discriminant analysis effect size) analysis^[@CR58]^ was used for the comparison of bacterial taxa relative abundances between genotypes, based on a Linear Discriminant Analysis (LDA) threshold score of 3. Specific taxa that contributed to group differences in the wt or (*Casp1, Ifngr and Nos2*)^−/−^ group following stress were identified using a canonical analysis of principal coordinates (CAP) plot generated based on the factors treatment (control, CUS) and time (baseline, 28 days). Within-group paired comparisons of the relative abundances of specific taxa were further assessed using the Wilcoxon test with a false discovery rate (FDR) correction for multiple testing. The significance level was set at 0.05 for all statistical tests.
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